113 related articles for article (PubMed ID: 18999159)
1. Polygenic model for predicting breast cancer risk via genome-wide polymorphisms.
Piccolo SR; Camp N; Frey LJ
AMIA Annu Symp Proc; 2008 Nov; ():1094. PubMed ID: 18999159
[TBL] [Abstract][Full Text] [Related]
2. Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping.
Ellis NA; Kirchhoff T; Mitra N; Ye TZ; Chuai S; Huang H; Nafa K; Norton L; Neuhausen S; Gordon D; Struewing JP; Narod S; Offit K
Genet Epidemiol; 2006 Jan; 30(1):48-61. PubMed ID: 16206141
[TBL] [Abstract][Full Text] [Related]
3. Ranking single nucleotide polymorphisms by potential deleterious effects.
Lee PH; Shatkay H
AMIA Annu Symp Proc; 2008 Nov; 2008():667-71. PubMed ID: 18999314
[TBL] [Abstract][Full Text] [Related]
4. Ability to predict breast cancer in Asian women using a polygenic susceptibility model.
Hartman M; Suo C; Lim WY; Miao H; Teo YY; Chia KS
Breast Cancer Res Treat; 2011 Jun; 127(3):805-12. PubMed ID: 21153878
[TBL] [Abstract][Full Text] [Related]
5. Polygenic predisposition to breast cancer and the risk of coronary artery disease.
D'Souza M; Schou M; Skals R; Weeke PE; Lee C; Smedegaard L; Madelaire C; Gerds TA; Poulsen HE; Hansen T; Grarup N; Pedersen O; Stender S; Engstrøm T; Fosbøl E; Nielsen D; Gislason G; Køber L; Torp-Pedersen C; Andersson C
Int J Cardiol; 2019 Sep; 291():145-151. PubMed ID: 31155334
[TBL] [Abstract][Full Text] [Related]
6. [How about the uncertainty in the haplotypes in the population-based KORA studies?].
Heid IM; Lamina C; Bongardt F; Fischer G; Klopp N; Huth C; Küchenhoff H; Kronenberg F; Wichmann HE; Illig T
Gesundheitswesen; 2005 Aug; 67 Suppl 1():S132-6. PubMed ID: 16032531
[TBL] [Abstract][Full Text] [Related]
7. [Polygenic risk prediction of common diseases: from epidemiology to clinical application].
Jansen PR; Broeders MJM; Cornel MC; Meijers-Heijboer H
Ned Tijdschr Geneeskd; 2019 Sep; 163():. PubMed ID: 31556493
[TBL] [Abstract][Full Text] [Related]
8. Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field.
Yanes T; Young MA; Meiser B; James PA
Breast Cancer Res; 2020 Feb; 22(1):21. PubMed ID: 32066492
[TBL] [Abstract][Full Text] [Related]
9. Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms.
Listgarten J; Damaraju S; Poulin B; Cook L; Dufour J; Driga A; Mackey J; Wishart D; Greiner R; Zanke B
Clin Cancer Res; 2004 Apr; 10(8):2725-37. PubMed ID: 15102677
[TBL] [Abstract][Full Text] [Related]
10. [Possibilities and limitations of genomic analyses in rheumatoid arthritis].
Drynda S; Kekow J
Z Rheumatol; 2009 Feb; 68(1):65-8. PubMed ID: 19145443
[TBL] [Abstract][Full Text] [Related]
11. Long-term prospective clinical follow-up after BRCA1/2 presymptomatic testing: BRCA2 risks higher than in adjusted retrospective studies.
Evans DG; Harkness E; Lalloo F; Howell A
J Med Genet; 2014 Sep; 51(9):573-80. PubMed ID: 25053764
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of CYP17A1 and LEP Gene Polymorphisms in Breast Cancer.
Karakus N; Kara N; Ulusoy AN; Ozaslan C; Tural S; Okan I
Oncol Res Treat; 2015; 38(9):418-22. PubMed ID: 26407154
[TBL] [Abstract][Full Text] [Related]
13. Utilizing Genetic Predisposition Score in Predicting Risk of Type 2 Diabetes Mellitus Incidence: A Community-based Cohort Study on Middle-aged Koreans.
Park HY; Choi HJ; Hong YC
J Korean Med Sci; 2015 Aug; 30(8):1101-9. PubMed ID: 26240488
[TBL] [Abstract][Full Text] [Related]
14. Genetic diversity in german and European populations: looking for substructures and genetic patterns.
Lamina C; Steffens M; Mueller J; Lohmussaar E; Meitinger T; Wichmann HE
Gesundheitswesen; 2005 Aug; 67 Suppl 1():S127-31. PubMed ID: 16032530
[TBL] [Abstract][Full Text] [Related]
15. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.
Antoniou AC; Pharoah PD; McMullan G; Day NE; Ponder BA; Easton D
Genet Epidemiol; 2001 Jul; 21(1):1-18. PubMed ID: 11443730
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
[TBL] [Abstract][Full Text] [Related]
17. Genome-based prediction of breast cancer risk in the general population: a modeling study based on meta-analyses of genetic associations.
van Zitteren M; van der Net JB; Kundu S; Freedman AN; van Duijn CM; Janssens AC
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):9-22. PubMed ID: 21212067
[TBL] [Abstract][Full Text] [Related]
18. A role for XRCC4 in age at diagnosis and breast cancer risk.
Allen-Brady K; Cannon-Albright LA; Neuhausen SL; Camp NJ
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1306-10. PubMed ID: 16835328
[TBL] [Abstract][Full Text] [Related]
19. [New genetic tests and their clinical utility for cancer screening].
Probst-Hensch NM; Brand A
Ther Umsch; 2013 Apr; 70(4):251-4; discussion 255-6. PubMed ID: 23535553
[TBL] [Abstract][Full Text] [Related]
20. Estimating cancer survival and clinical outcome based on genetic tumor progression scores.
Rahnenführer J; Beerenwinkel N; Schulz WA; Hartmann C; von Deimling A; Wullich B; Lengauer T
Bioinformatics; 2005 May; 21(10):2438-46. PubMed ID: 15705654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
